A Study on Factors of Biochemical Response in Autoimmune Hepatitis

Status Not yet recruiting

Clinical Trial Summary

The goal of this observational study is to clarify the clinical characteristics of autoimmune hepatitis (AIH) in China. The main questions it aims to answer are: Human leukocyte antigen (HLA) gene susceptibility in Chinese AIH patients prognostic factors associated with AIH Participants will provide liver tests results and details of treatment during follow-up.

Clinical Trial Description

This study aims to establish a high-quality, standardized prospective cohort of AIH with regular follow-up, clarify the clinical characteristics of AIH in China, construct a prognostic model, and explore new serum markers or AIH gene susceptibility, so as to provide key clinical evidence for the prevention and treatment of AIH in China. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06356506
Study type	Observational
Source	Beijing Friendship Hospital
Contact	Yu Su
Phone	18810639513
Email	suyu_7912@163.com
Status	Not yet recruiting
Phase
Start date	May 1, 2024
Completion date	May 1, 2034

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06020976` - Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital
Recruiting	`NCT05476900` - A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.	Phase 2
Recruiting	`NCT05635266` - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Recruiting	`NCT06250309` - Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients	N/A
Recruiting	`NCT01661842` - Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis	Phase 1/Phase 2
Terminated	`NCT04339621` - AIH Risk Stratification With Multiparametric MRI
Not yet recruiting	`NCT04371718` - Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)	Phase 2
Completed	`NCT02239562` - sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS	Phase 1
Recruiting	`NCT05569759` - A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)	Phase 2
Completed	`NCT02463331` - Association of Chloroquine and Prednisone as an Alternative Treatment for Autoimmune Hepatitis	Phase 4
Terminated	`NCT04203875` - Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis	Phase 1
Recruiting	`NCT06078098` - Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
Completed	`NCT00838214` - Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis	Phase 2/Phase 3
Recruiting	`NCT05810480` - PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G
Recruiting	`NCT03743272` - Repeatability and Reproducibility of Multiparametric MRI
Completed	`NCT03979053` - Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.
Not yet recruiting	`NCT04902807` - Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Recruiting	`NCT04933292` - A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome	Phase 4
Not yet recruiting	`NCT06455280` - SIPLIZUMAB in AILD and LT	Phase 1
Completed	`NCT05532345` - Discrimination of DILI and AIH by Artificial Intelligence